Company / Book Value per Share
Syndax Pharmaceuticals Inc Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.754
FY2025
5-year range
$0.66 / $8.502
FY2021-FY2025
Trend
-77.8%
vs FY2024
Sector context
#175 of 209
Health Care
What the data says
Syndax Pharmaceuticals Inc's book value per share of $0.754 is lower than 84% of companies in the Health Care sector (FY2025). Book Value per Share has declined for 3 consecutive years, from $8.502 in FY2022 to $0.754 in FY2025.
Based on SEC 10-K filings.
$0.754 in FY2025 with a 5-year CAGR of -17.3%.
Declined from $8.137 to $0.754 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -55.4%
- 5-Year CAGR
- -17.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 209This company $0.754 Sector average $189.406
▼
-99.6% below sector average
Key checks
Key Insights
- Syndax Pharmaceuticals Inc's book value per share has declined for 3 consecutive years.
- 5-year CAGR of -17.3%, indicating a declining trend.
- In FY2025, book value per share decreased 77.8% year-over-year.
- Ranks #175 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.754 | -77.8% |
| FY2024 | $3.397 | -58.3% |
| FY2023 | $8.137 | -4.3% |
| FY2022 | $8.502 | +1188.2% |
| FY2021 | $0.66 | -66.2% |
| FY2020 | $1.955 | -53.5% |
| FY2019 | $4.2 | +21.8% |
| FY2018 | $3.45 | +124.9% |
| FY2017 | -$13.857 | +99.2% |
| FY2016 | -$1.8K | +51.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026